Intravascular lithotripsy-enabled vascular access for transfemoral TAVR was evaluated in a prospective registry, but the provided abstract is truncated and reports no quantitative results.
Observational
Randomized controlled trials of transcatheter aortic valve replacement (TAVR) included both transfemoral and alternative access approaches for valve delivery (1), but the best outcome, superiority to surgical aortic valve replacement, was only achieved in transfemoral patients (2,3). Unfortunately, a significant number of patients remain ineligible for routine transfemoral access due to peripheral arterial disease, which precludes delivery of large-diameter transcatheter valve delivery systems
Mario et al. (Fri,) conducted a observational in Transcatheter aortic valve replacement in patients with peripheral arterial disease. Intravascular Lithotripsy-Enabled Vascular Access was evaluated. Intravascular lithotripsy-enabled vascular access for transfemoral TAVR was evaluated in a prospective registry, but the provided abstract is truncated and reports no quantitative results.